Agile Therapeutics Inc COM PAR $0.0001 (OTC:AGRX) Stock, Earnings Estimates, EPS, And Revenue

Agile Therapeutics Inc COM PAR $0.0001 reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Aug 12
EPS
$-1.730
Quarterly Revenue
$5.6M
Annual Revenue

Analyze the earnings history of Agile Therapeutics Inc COM PAR $0.0001 using advanced sorting and filters.

Data brought to you by Benzinga APIs

Agile Therapeutics Inc COM PAR $0.0001 (AGRX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Mar 20242024-05-15$-0.63$-0.51-23.5 %
Dec 20232024-03-28$-1.46$-0.92-58.7 %
Sep 20232023-11-09$-1.47$-1.8420.1 %
Jun 20232023-08-09$-3.10$-3.4810.9 %

Agile Therapeutics Inc COM PAR $0.0001 (AGRX) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Mar 20242024-05-15$5.72M$3.75M52.4 %
Dec 20232024-03-28$3.62M$4.07M-11.2 %
Sep 20232023-11-09$6.66M$5.27M26.4 %
Jun 20232023-08-09$5.50M$4.68M17.6 %

FAQ

Q

When is Agile Therapeutics Inc COM PAR $0.0001 (OTC:AGRX) reporting earnings?

A

Agile Therapeutics Inc COM PAR $0.0001 (AGRX) is scheduled to report earnings on December 3, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Agile Therapeutics Inc COM PAR $0.0001 (OTC:AGRX)?

A

The Actual EPS was $-1.73, which missed the estimate of $0.00.

Q

What were Agile Therapeutics Inc COM PAR $0.0001’s (OTC:AGRX) revenues?

A

The Actual Revenue was $5.6M, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.